Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 104

Similar articles for PubMed (Select 15602502)

1.

Levodopa challenge neuroimaging of levodopa-related mood fluctuations in Parkinson's disease.

Black KJ, Hershey T, Hartlein JM, Carl JL, Perlmutter JS.

Neuropsychopharmacology. 2005 Mar;30(3):590-601.

2.

Non-motor dopamine withdrawal syndrome after surgery for Parkinson's disease: predictors and underlying mesolimbic denervation.

Thobois S, Ardouin C, Lhommée E, Klinger H, Lagrange C, Xie J, Fraix V, Coelho Braga MC, Hassani R, Kistner A, Juphard A, Seigneuret E, Chabardes S, Mertens P, Polo G, Reilhac A, Costes N, LeBars D, Savasta M, Tremblay L, Quesada JL, Bosson JL, Benabid AL, Broussolle E, Pollak P, Krack P.

Brain. 2010 Apr;133(Pt 4):1111-27. doi: 10.1093/brain/awq032. Epub 2010 Mar 17.

3.
4.

Rhythm-specific modulation of the sensorimotor network in drug-naive patients with Parkinson's disease by levodopa.

Esposito F, Tessitore A, Giordano A, De Micco R, Paccone A, Conforti R, Pignataro G, Annunziato L, Tedeschi G.

Brain. 2013 Mar;136(Pt 3):710-25. doi: 10.1093/brain/awt007. Epub 2013 Feb 18.

5.

The long-acting dopamine receptor agonist cabergoline in early Parkinson's disease: final results of a 5-year, double-blind, levodopa-controlled study.

Bracco F, Battaglia A, Chouza C, Dupont E, Gershanik O, Marti Masso JF, Montastruc JL; PKDS009 Study Group.

CNS Drugs. 2004;18(11):733-46. Erratum in: CNS Drugs. 2005;19(7):633.

PMID:
15330687
6.
7.

Age at onset influences neurodegenerative processes underlying PD with levodopa-induced dyskinesias.

Cerasa A, Salsone M, Morelli M, Pugliese P, Arabia G, Gioia CM, Novellino F, Quattrone A.

Parkinsonism Relat Disord. 2013 Oct;19(10):883-8. doi: 10.1016/j.parkreldis.2013.05.015. Epub 2013 Jun 14.

PMID:
23769805
8.

Mood response to levodopa infusion in early Parkinson's disease.

Maricle RA, Valentine RJ, Carter J, Nutt JG.

Neurology. 1998 Jun;50(6):1890-2.

PMID:
9633754
9.
10.

Mood swings associated with the 'on-off' phenomenon in Parkinson's disease.

Nissenbaum H, Quinn NP, Brown RG, Toone B, Gotham AM, Marsden CD.

Psychol Med. 1987 Nov;17(4):899-904.

PMID:
3432464
11.

Dopaminergic modulation of cognitive interference after pharmacological washout in Parkinson's disease.

Fera F, Nicoletti G, Cerasa A, Romeo N, Gallo O, Gioia MC, Arabia G, Pugliese P, Zappia M, Quattrone A.

Brain Res Bull. 2007 Sep 14;74(1-3):75-83. Epub 2007 Jun 6.

PMID:
17683792
12.
13.

Levodopa-related motor complications--phenomenology.

Fox SH, Lang AE.

Mov Disord. 2008;23 Suppl 3:S509-14. doi: 10.1002/mds.22021. Review.

PMID:
18781677
14.

Levodopa influences striatal activity but does not affect cortical hyper-activity in Parkinson's disease.

Martinu K, Degroot C, Madjar C, Strafella AP, Monchi O.

Eur J Neurosci. 2012 Feb;35(4):572-83. doi: 10.1111/j.1460-9568.2011.07979.x. Epub 2012 Feb 3.

PMID:
22304628
15.

Prefrontal alterations in Parkinson's disease with levodopa-induced dyskinesia during fMRI motor task.

Cerasa A, Pugliese P, Messina D, Morelli M, Gioia MC, Salsone M, Novellino F, Nicoletti G, Arabia G, Quattrone A.

Mov Disord. 2012 Mar;27(3):364-71. doi: 10.1002/mds.24017. Epub 2011 Nov 10.

PMID:
22076870
16.

Does levodopa slow or hasten the rate of progression of Parkinson's disease?

Fahn S; Parkinson Study Group.

J Neurol. 2005 Oct;252 Suppl 4:IV37-IV42. Review.

PMID:
16222436
17.

Dopaminergic modulation of striato-frontal connectivity during motor timing in Parkinson's disease.

Jahanshahi M, Jones CR, Zijlmans J, Katzenschlager R, Lee L, Quinn N, Frith CD, Lees AJ.

Brain. 2010 Mar;133(Pt 3):727-45. doi: 10.1093/brain/awq012.

18.

The relationship between depression and regional cerebral blood flow in Parkinson's disease and the effect of selegiline treatment.

Imamura K, Okayasu N, Nagatsu T.

Acta Neurol Scand. 2011 Jul;124(1):28-39. doi: 10.1111/j.1600-0404.2010.01443.x. Epub 2010 Sep 29. Erratum in: Acta Neurol Scand. 2011 Sep;124(3):221-2.

PMID:
20880269
19.

Task specific influences of Parkinson's disease on the striato-thalamo-cortical and cerebello-thalamo-cortical motor circuitries.

Lewis MM, Slagle CG, Smith AB, Truong Y, Bai P, McKeown MJ, Mailman RB, Belger A, Huang X.

Neuroscience. 2007 Jun 15;147(1):224-35. Epub 2007 May 17.

20.

Involvement of the subthalamic nucleus in impulse control disorders associated with Parkinson's disease.

Rodriguez-Oroz MC, López-Azcárate J, Garcia-Garcia D, Alegre M, Toledo J, Valencia M, Guridi J, Artieda J, Obeso JA.

Brain. 2011 Jan;134(Pt 1):36-49. doi: 10.1093/brain/awq301. Epub 2010 Nov 8.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk